Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

The Phase 1 trial, fully funded by a U.S. Department of Defense grant awarded to Cleveland Clinic, is nearing enrollment completion. Monitoring and data analysis will continue over the next three to ...

The oncology business, meanwhile, would be biologics-focused and feature lead drug nemvaleukin alfa – an IL-2 therapy in phase 3 testing alongside Merck & Co's Keytruda (pembrolizumab ...

Researchers made small tweaks to the molecular structure of LSD to see if it could be turned into an effective brain-healing ...

Skeletal editing is a modern approach to chemical synthesis. By making precise alterations at the atomic level, researchers ...

Chemists have developed an efficient skeletal editing method for frequently used heteroaromatic structures. The technique could serve as a means to chemically modify biologically active compounds.

A team of scientists has answered a long-standing question in cell biology, uncovering how the cell's main energy currency, ...

CytomX Therapeutics is testing CX-801 with Keytruda in a phase 1 trial for metastatic melanoma, focusing on safety and clinical activity. The trial is conducted at UCSF and the University of ...

Researchers at the Institute for Basic Science (IBS) have identified a remarkably small but critical piece of genetic code ...